| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6487654 | Current Opinion in Biotechnology | 2015 | 7 Pages |
Abstract
- Microorganisms are a versatile platform for the production of therapeutic proteins.
- N-glycosylation engineering of fungi and bacteria produces humanlike glycans.
- Improving glycosylation efficiency in Escherichia coli is challenging.
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Bioengineering
Authors
Diana Chinyere Anyaogu, Uffe Hasbro Mortensen,